Efficacy of BRAF/MEK-inhibitor therapy for epithelioid glioblastoma with a novel BRAFV600 mutation.
Steininger J, Buszello C, Oertel R, Meinhardt M, Schmid S, Engellandt K, Herold S, Stasik S, Ebrahimi A, Renner B, Thiede C, Eyüpoglu IY, Schackert G, Beissert S, Meier F, Radke J, Westphal D, Juratli TA.
Steininger J, et al. Among authors: juratli ta.
Acta Neuropathol Commun. 2024 Aug 6;12(1):124. doi: 10.1186/s40478-024-01834-8.
Acta Neuropathol Commun. 2024.
PMID: 39107839
Free PMC article.